AI Article Synopsis

  • - Smallpox, caused by the variola virus, was eradicated in 1979 but remains a potential biological weapon due to its high contagion and mortality rate of up to 30%.
  • - Researchers developed a peptide vaccine using immunoinformatics tools to activate immunity against the variola virus, focusing on safe and effective T-cell and B-cell epitopes with a strong binding affinity to immune receptors.
  • - This new vaccine design not only aims to provide effective protection against the variola virus but also offers insights into vaccine strategies for current threats like monkeypox.

Article Abstract

Unlabelled: Smallpox is a highly contagious human disease caused by the variola virus. Although the disease was eliminated in 1979 due to its highly contagious nature and historical pathogenicity, with a mortality rate of up to 30%, this virus is an important candidate for biological weapons. Currently, vaccines are the critical measures to prevent this virus infection and spread. In this study, we designed a peptide vaccine using immunoinformatics tools, which have the potential to activate human immunity against variola virus infection efficiently. The design of peptides derives from vaccine-candidate proteins showing protective potential in vaccinia WR strains. Potential non-toxic and nonallergenic T-cell and B-cell binding and cytokine-inducing epitopes were then screened through a priority prediction using special linkers to connect B-cell epitopes and T-cell epitopes, and an appropriate adjuvant was added to the vaccine construction to enhance the immunogenicity of the peptide vaccine. The 3D structure display, docking, and free energy calculation analysis indicate that the binding affinity between the vaccine peptide and Toll-like receptor 3 is high, and the vaccine receptor complex is highly stable. Notably, the vaccine we designed is obtained from the protective protein of the vaccinia and combined with preventive measures to avoid side effects. This vaccine is highly likely to produce an effective and safe immune response against the variola virus infection in the body.

Importance: In this work, we designed a vaccine with a cluster of multiple T-cell/B-cell epitopes, which should be effective in inducing systematic immune responses against variola virus infection. Besides, this work also provides a reference in vaccine design for preventing monkeypox virus infection, which is currently prevalent.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237557PMC
http://dx.doi.org/10.1128/spectrum.00465-24DOI Listing

Publication Analysis

Top Keywords

virus infection
20
variola virus
16
vaccine
10
highly contagious
8
peptide vaccine
8
virus
7
infection
5
designing smallpox
4
smallpox b-cell
4
b-cell t-cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!